INTRODUCTION
Cryptococcal meningitis causes 20-25% of AIDSrelated mortality worldwide [1] . In sub-Saharan Africa, Cryptococcus is the most common cause of meningitis in adults, accounting for 26% of cases in Malawi, 45% in Zimbabwe, 30% in South Africa, and 60% in Uganda [2] [3] [4] [5] [6] . Despite antiretroviral therapy (ART) scale-up, many patients with a new HIV diagnosis still present with very low CD4 þ T cells (<200 cells/ml) [7] and opportunistic infections, such as cryptococcal meningitis, because of failure to initiate ART in a timely manner and poor linkage to HIV care.
Initiation of ART can be complicated by immune reconstitution inflammatory syndrome (IRIS), which contributes to the mortality following Primary immune deficiencies of CD4 þ T cells, impaired phagocytic function of macrophages, and variants in major histocompatibility complex molecules I/II are associated with development of serious cryptococcal infections [23, 24] . Similarly, patients with X-linked hyper-IgM and hyper-IgE syndromes, and those with secondary immune disorders, such as malignancies, solid organ transplants, use of immunosuppressant drugs, and with HIV infection show a similar predisposition [25, 26] . In healthy humans, the initial immune response involves fungal recognition by lung innate immune cells and generation of signals that lead to expansion of Cryptococcus-specific CD4 þ T cells to control the infection [27] . Minimal trafficking of immune cells to the cerebrospinal fluid (CSF) occurs in severely immunosuppressed HIV-infected patients with cryptococcal meningitis [28 & ]. The primary immune response to cryptococcal infection may determine the mechanisms that eventually cause cryptococcal IRIS.
In the brain, glucuronoxylomannan, the principal component of the cryptococcal polysaccharide capsule, binds to macrophage FcgRIIIB, which inhibits the Fcg receptor and proinflammatory cytokine expression [29, 30] , whereas mannoprotein induces antigen-specific T-cell responses [31] . Cryptococcus neoformans promotes an imbalance toward a Th2 response by suppressing Th1 responses [32] [33] [34] . Uncontrolled murine cerebral cryptococcosis results from IL-4/IL-13-dependent alternative activation of macrophages [35] . Consistent with these observations, patients who later develop CM-IRIS show higher baseline serum levels of Th2 cytokines (IL-4 and IL-13), lower levels of TNF-a [19] , and lower CSF levels of IFN-g [36] at cryptococcal meningitis diagnosis compared with those who do not develop CM-IRIS. Cryptococcus inhibits T-cell migration into the CSF by increasing L-selectin shedding from T cells, limiting their ability to extravasate into the CNS [37, 38] . The imbalance of these functional immune constituents may underlie the pathologic clinical outcome of ART-induced IRIS during cryptococcal infection. In patients with AIDS, Cryptococcus establishes a chronic infection. Upon ART-associated immune recovery, the persistent fungal antigen burden is proposed to trigger an exaggerated inflammatory response because of HIV-associated impairment of homeostatic regulatory mechanisms [39] .
IMMUNE RECONSTITUTION WITH ANTIRETROVIRAL THERAPY
During early HIV infection, HIV-specific immune responses limit viral replication and the destruction of CD4 þ T cells is balanced by the generation of new CD4 þ T cells [40] . Over time, ongoing viral replication, immune cell depletion and dysregulation are associated with chronic inflammation, resulting in scarring and destruction of the normal lymph node architecture [41] . ART suppresses HIV replication and CD4 þ T-cell apoptosis, allowing immune regeneration. During immune reconstitution, CD4 þ T cells increase rapidly (26 cells/ml/month) [42] , some pathogen-specific immune responses recover [43 & ], a decreased susceptibility to opportunistic infections is observed, and genes encoding innate antiviral responses, immune activation, cellular proliferation, and apoptosis are downregulated [44] . HIV infection also affects the innate immune axis, with expansion of monocytes [45] , whereas immune reconstitution decreases the activation of monocytes/macrophages [46] .
KEY POINTS
Poor cryptococcal antigen clearance is important in the development of cryptococcal IRIS.
Monocyte recruitment into the CSF compartment during CM-IRIS may be essential for the subsequent cytokinedriven immunopathology that occurs during CM-IRIS.
The confluence of residual cryptococcal antigen, chemokine-mediated trafficking of monocytes, and ARTmediated CD4 þ T-cell redistribution into the CNS may spawn exaggerated innate and adaptive immune responses that define cryptococcal IRIS.
Future therapeutic interventions to prevent or treat cryptococcal IRIS could utilize our current understanding of the cellular kinetics of innate and adaptive cells in the CNS. 
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EPIDEMIOLOGY OF CRYPTOCOCCAL MENINGITIS IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME
An estimated 10-25% of persons without a known opportunistic infection who start ART experience IRIS [40, [47] [48] [49] . IRIS has been associated with more than 20 infectious pathogens [Mycobacterium avium complex, Mycobacterium tuberculosis, C. neoformans, cytomegalovirus, John Cunningham virus, Pneumocystis jirovecii, herpes zoster (varicella zoster virus), and hepatitis B and C], malignancy (Kaposi's sarcoma), and occasionally noninfectious autoimmune syndromes and malignancies [40, 41, 47, 48] . The majority of IRIS events will occur within the first 8 weeks of ART; however, delayed IRIS occurring years later has also been described, particularly for cryptococcal IRIS and CM-IRIS [11, 50] . Approximately 25% of cryptococcal meningitis patients treated with antifungals and ART [8, 9, 16] will experience paradoxical deterioration, despite decreasing fungal burden [8, 16, 19, 51] (Table 1) . Cryptococcal IRIS may manifest as relapsing aseptic meningitis, increased intracranial pressure, new focal neurologic signs, intracranial cryptococcomas, lymphadenopathy, and/or development of abscesses [11, 19, [52] [53] [54] , which can present as multifocal or multiphasic disease [55 & ]. Mortality associated with cryptococcal IRIS ranges from 0 to 67% [19, 20, 50] .
In the absence of HIV coinfection, cryptococcal IRIS has also been described with reversal of iatrogenic immunosuppression. Cutaneous cryptococcal IRIS was reported in a patient with T-cell prolymphocytic leukemia [56] following use of alemtuzumab, a monoclonal antibody that blocks CD52 þ , a surface ligand involved in immune cell mobility [57] . TNF-a inhibitors have also been associated with an increased risk of cryptococcal infections [58] [59] [60] , highlighting the important role played by TNF-a in the immune response against Cryptococcus [61] .
CASE DEFINITION -CRYPTOCOCCAL IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME
The International Network for the Study of HIVassociated IRIS has developed a consensus case definition for CM-IRIS [51] ( Supplementary Table 1 , http://links.lww.com/COID/A12). IRIS remains a diagnosis of exclusion, after considering adverse drug reactions, new opportunistic infections, and microbiologic treatment failure (whether because of drug resistance or malabsorption). Differentiation of IRIS from these other diagnoses has important implications that may impact clinical management and outcomes.
CLINICAL RISK FACTORS FOR CRYPTOCOCCAL IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME
The immune response to Cryptococcus requires both the innate and adaptive immune axes to be functionally coupled to control the infection [62 & ,63] . During HIV infection, the adaptive immune response is severely compromised and fungal dissemination to the meninges occurs in the absence of antifungal therapy. ART alone is insufficient to prevent cryptococcal disease when subclinical infection is present [64] . Microbiologic, virologic, immunologic, and therapeutic factors may affect the incidence of CM-IRIS ( Table 2 ).
PROPOSED IMMUNOLOGIC MECHANISMS FOR CRYPTOCOCCAL MENINGITIS IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME
We highlight three stages of CM-IRIS pathogenesis ( Table 3) : pre-ART paucity of inflammation, immune system dysfunction, and/or anergy resulting in poor macrophage killing and clearance of cryptococcal organisms; macrophages are poised to receive missing T-cell signals, such as from IFNg, which are restored after ART initiation and induce cryptococcal killing triggering an inflammatory response; and dysregulated homeostatic and regulatory mechanisms leading to exaggerated responses.
PHASE 1: PAUCITY OF INFLAMMATORY RESPONSE
Neutrophil migration and fungistatic activity is impaired during HIV infection [74] . Poor CSF cytokine responses predispose to poor antigen clearance and increase the risk of IRIS. At cryptococcal meningitis diagnosis, three of five studies suggest a paucity of inflammation increases the risk of developing CM-IRIS (Table 4 ). Significant elevation of cells and protein is not consistently demonstrated. HIV-uninfected patients with cryptococcal meningitis show a more robust immune response in CSF. Patients with HIV infection had higher cryptococcal antigen titers at baseline, with a significant decrease at CM-IRIS. It remains unclear whether the changes that occur at CM-IRIS suggest a recovering immune system responding normally or reflect exaggerated immune responses to residual cryptococcal antigen. The recurrence of symptoms/signs of meningitis associated with CM-IRIS in the setting of negative CSF cultures, however, appears to fit the latter. Table 5 summarizes studies that have measured cytokines/chemokines in blood and CSF among patients with cryptococcal meningitis or CM-IRIS. These data suggest that cryptococcal meningitis patients with decreased innate (IL-6, IL-8, and TNF-a) and adaptive inflammatory cytokines (IFN-g) at cryptococcal meningitis diagnosis are at higher risk of developing CM-IRIS. Elevation of the Table 3 . Summary of paradoxical cryptococcal-IRIS pathogenesis framework [19] Phase
Immunologic activity Evidence in CM-IRIS patients
Before ART Paucity of appropriate inflammation for cryptococcosis # TNF-a, G-CSF, GM-CSF, VEGF in serum # IFN-g, G-CSF, TNF-a, IL-6 in CSF [21, 36] Inappropriate (Th2) responses resulting in: " IL-4 pre-ART Poor antigen clearance, pre-ART Similar CSF CRAG at initial infection [36] Higher CRAG pre-ART Elevated CSF chemokine expression " Expression of CCL2, CCL3 in CSF [71] After starting ART Increasing proinflammatory signaling from APCs because of persisting antigen burden and failure to clear antigen " IL-6 from macrophages [72] 
Higher viral load prior to ART initiation
AELower pre-ART CD4 þ cell count [21, 66] Very early ART initiation in relation to diagnosis and therapy of CM [67] [68] [69] [70] A robust virologic response to ART with a rapid decline in VL [16] AEA robust immunologic responses to ART with rapid CD4 þ T-cell increase [16] ] show during cryptococcal meningitis, natural killer cells are involved in CNS immune regulation during the primary response to cryptococcal infection via elevated expression of the chemokines CXCR3, CX3CR1, and diminished TNF-a in CSF. We have demonstrated elevated frequencies of TNF-a-and IL-6-producing monocytes at CM-IRIS compared with ART matched controls without CM-IRIS [73 & ].
The timing of ART initiation in relation to diagnosis and therapy of cryptococcal meningitis may affect the incidence of CM-IRIS [8, 18, 19, 65, 67, 68 & ,70]; however, the increased incidence of cryptococcal IRIS with earlier ART initiation has not been consistent across cohorts. The excess deaths occurring with earlier ART initiation may be distinct IRIS events although clinically indistinguishable from deterioration because of cryptococcosis.
PHASE 2: INNATE CELL ACTIVATION
Wiesner and Boulware [81] propose that in the early stages of ART immune recovery, in the absence of an effective T-cell response, foreign antigens generate HIV positive with CM-IRIS (baseline) (n ¼ 9) ongoing proinflammatory signaling by antigenpresenting cells, demonstrated by increasing serum IL-6 and C reactive protein in the weeks prior to the IRIS event [19] . The corresponding effector response is delayed until a cytokine storm predominated by a Th1 response occurs at the time of IRIS in blood and CSF [19, 36] . Similarly, Barber and colleagues [82 && ] suggest that, prior to ART, killing of intracellular pathogens by innate phagocytes is defective in the absence of IFN-g signaling from CD4 þ T cells. They further propose that partially primed myeloid cells accumulate with disease progression and the creation of a hyperresponsive state of the innate immune cells. Upon immune [19, 36] HIV positive at CM-IRIS (n ¼ 85) reconstitution of CD4 þ T-cell help with ART, broad activation of these myeloid cells results in the production of proinflammatory mediators, eliciting the immunopathology defining IRIS. Thus, IRIS is thought to result from uncoupling of the innate and adaptive immune axes following repletion of HIV-associated CD4 þ T-cell number and function with ART. Differences in chemokine and cytokine expression occur in CSF and blood compartments pre-ART and during CM-IRIS with increased expression of CCL2 (monocyte chemo attractant protein-1, MCP-1) and CCL3 (macrophage inflammatory protein 1-a, or MIP 1-a) [80 & ]. These chemokines recruit myeloid cells into the CNS, suggesting monocyte recruitment into the CSF occurs during CM-IRIS. CCL2 and CCL3 were also higher in CSF of patients who remained culture positive following antifungal therapy, reflecting ongoing innate antigen-presenting cell signaling among this culture-positive group with a higher risk of developing CM-IRIS. More recently, Jarvis et al. [71] have demonstrated that elevated CCL2 and CCL3 levels in CSF, low peripheral CD4 þ T cells, and low CSF white cell numbers at cryptococcal meningitis diagnosis were predictive of CM-IRIS. The authors suggest that over-recruitment of myeloid cells into the CNS could lead to exaggerated immune responses that drive the immunopathology observed during CM-IRIS. Three subsets of monocytes are known to be present in blood depending on their degree of expression of the CD14 surface marker: classical monocytes (CD14 þþ CD16 À ), intermediate monocytes (CD14 þþ CD16 þ ), and the nonclassical monocyte (CD14 þ CD16 þþ monocyte) [83] . We have recently demonstrated differences in phenotype and activation of monocytes and CD4 þ T cells in blood compared with CSF during CM-IRIS, with the more proinflammatory intermediate monocytes ].
#IFN
We surmise that localized immune responses, particularly monocyte innate immune responses, are involved in the immunopathology during CM-IRIS.
PHASE 3: IMMUNE DYSREGULATION
Almost every constituent of the immune system is deranged during very advanced HIV infection, the time at which cryptococcal meningitis occurs (CD4 þ T cells 15-30 cells/ml).
Regulatory T cells
Regulatory T cells downregulate immune responses to foreign antigens to prevent collateral damage from inflammatory responses [39] . However, a dampened immune response could also have the detrimental effect of delaying antigen clearance during acute infection [85] . A decrease in regulatory T cells at IRIS is thought to predispose to dysregulated effector responses. A higher proportion of regulatory T cells among patients who developed CM-IRIS compared with healthy controls at baseline was found in one study [86] whereas substantial quantitative expansion of these cells with defective immunosuppressive function was found in another study during IRIS [87] . Several studies show no association between decreased proportions of regulatory T cells, including the T effector/T regulatory ratio, and IRIS [86, 88, 89] suggesting that these cells may have a limited role in the pathogenesis of CM-IRIS; however, anti-TNF-a molecules in cryptococcal IRIS enhance regulatory T cells and Th2 predominance over Th1 responses [90 & ]. Further studies focusing on the functional role of regulatory T cells during CM-IRIS are warranted.
Innate immune axis
Gene expression signatures related to infection and inflammation in circulating monocytes prior to ART initiation and at tuberculosis-associated IRIS (TB-IRIS) [91 & ,92] demonstrate that increased numbers and activation of the classical monocyte subset appear to functionally predispose to and mediate the development of TB-IRIS with increased expression of IL-1b, IL-6, and tumor necrosis factor during TB-IRIS [93 && ]. Monocytes represent a smaller minority population in the CSF (8-10% of mononuclear cells [46, 94] ) in healthy adults. However, during CM-IRIS, CSF monocyte subsets shift from classical to an intermediate/proinflammatory subset, with elevated programmed death ligand-1 expression on monocytes and natural killer cells 
Lymphopenia-induced proliferation
Space-driven homeostatic compensatory T-cell proliferation occurring soon after ART initiation could link the innate and adaptive immune responses that are observed at CM-IRIS. Lymphopenia that occurs in HIV infection drives the homeostatic proliferation of memory-like T cells [97, 98] . Spontaneous proliferation could be induced by high-affinity major histocompatibility complex/peptide interactions occurring in the presence of residual cryptococcal antigens and monocyte-derived IL-6 [99] [100] [101] [102] . Elevated IL-6 and TNF-a-expressing monocytes pre-ART [73 & ] and an increase in IL-6 prior to development of CM-IRIS [19] appear to confirm a role for IL-6. Spontaneous proliferation causes naïve T cells to acquire the phenotypic and functional properties of effector memory cells [103] that upregulate IFN-g expression and related Th1 responses that predominate during CM-IRIS as the state of immune suppression is reversed. Additionally, IL-2, IL-4, IL-7, and IL-15 favor memory T-cell survival and expansion [87, 104, 105] . It is plausible that IL-6 produced by monocytes drives the proliferation and expansion of antigen-specific CD4 þ T-cell memory cells, which then provide signaling that fully activates macrophages primed by Cryptococcus in the brain parenchyma, with a resultant spike in inflammation in CSF during CM-IRIS.
That T cells play a pathogenic role in CM-IRIS is supported by both indirect evidence from cytokine studies both in blood and CSF, prior to ART initiation and at the time of IRIS [19, 36] , as well as direct evidence of an influx of CD4 þ T cells into the CSF at the time of IRIS [28 & ]. The restoration of memory T-cell responses coupled with dysregulated memory responses against existing residual antigen have been considered the source of this exuberant secretion of cytokines resulting in a 'cytokine storm' proposed to underlie CM-IRIS [106] . However, the degree of inflammation present in the CSF at the time of CM-IRIS for such a 'cytokine storm' is not supported by the literature (Table 4 ). Rather, cellular and cytokine responses in CSF are actually quite similar to the cytokine levels present during initial cryptococcal meningitis among non CM-IRIS patients [16, 36] . One potential confounding issue is that just as results in blood likely do not accurately reflect processes in the CSF, CSF may not be the best monitor of IRIS abnormality but is merely the most accessible. IRIS abnormality may be occurring primarily in the brain tissue, for which CSF is only a surrogate. Autopsy studies may help to clarify these compartmental differences, including the idea that during CM-IRIS, highly differentiated polyfunctional antigen-specific CD4 þ T cells are expanded, and less so, the CD8 þ T cells [106] .
Effector T cells and cytokine responses
Dysregulated expansion of activated antigenspecific T cells as severe immune suppression reverses following ART initiation is thought to drive CM-IRIS. A functionally impaired yet predominantly highly activated CD4 þ T-cell effector memory phenotype in blood is characteristic of patients with IRIS prior to and during IRIS episodes [89] . Pre-ART, programmed death-1, an inhibitory receptor that is upregulated on T cells following antigen stimulation, was elevated on both CD4 þ and CD8 þ T cells among patients who developed IRIS compared with non-IRIS controls [89] , suggesting defects in T-cell inhibitory control [89] . Further, a robust increase of polyfunctional, highly differentiated effector memory CD4 þ T-cell responses specifically against the underlying pathogen is a distinctive feature of IRIS [106] , although T cells reactive with some pathogens may not recover with ART [43 & ]. Cytokines and chemokines measured in the CSF or blood provide insight into the mechanisms of CM-IRIS from patterns pre-ART or during IRIS events. IFN-g largely defines Th1 responses with possible contributions from IL-2 and TNF-a whereas IL-4, IL-5, and IL-13 denote Th2 responses. A paucity of Th1 responses in CSF at cryptococcal meningitis diagnosis, thought to be associated with poor cryptococcal clearance, is considered a risk factor for developing future CM-IRIS [36] . However, an increase in the Th1 response in CSF coincides with an increase in CD4 þ T cells in CSF with ART during CM-IRIS [28 & , 36, 107] . These cytokine responses could be identified both in CSF and in peripheral blood [19, 108] . Of note, localized responses in CSF at the site of the effective response may not parallel those in blood [19, 36] . Understanding these cytokine responses could be useful in developing measurable biomarkers to stratify the risk of developing CM-IRIS and immunologic endpoints for therapeutic intervention studies to treat or prevent CM-IRIS. A proposed integrated model characterizing these features of cryptococcal meningitis IRIS pathogenesis is highlighted in Figure 1 .
FUTURE PERSPECTIVES
Despite the benefits of ART in HIV-infected patients with cryptococcal meningitis, a dysregulated immune system after ART initiation poses clinical challenges. As advances are made in understanding the mechanistic pathways for paradoxical CM-IRIS, evidence of innate immune responses, specifically monocytes in the events leading up to paradoxical CM-IRIS, is emerging. Our understanding of the effector immune responses involved in the pathogenesis of unmasking CM-IRIS remains to be elucidated.
Earlier initiation of ART soon after the diagnosis of cryptococcal meningitis when antigen levels are high is associated with worse outcomes [68 & ]. However, these excess early deaths were not directly related to the development of paradoxical IRIS, at least using current case definitions [51] . This clinical definition may be modified to include innate and adaptive biomarkers as we develop a more mechanistic understanding of the immunopathogenesis of CM-IRIS.
Because the dysregulated expansion of antigenspecific T cells [106] during paradoxical CM-IRIS occurs in the setting of residual cryptococcal antigen, decreasing the fungal burden more rapidly with more effective fungicidal agents in the induction phase of cryptococcal meningitis treatment is germane. Such treatments may include customized therapy using higher doses of fluconazole and a longer duration of amphotericin or flucytosine for patients with high fungal burden, use of adjunctive IFN-g [21] , and other antifungal drugs such as sertraline [71, 80] Decreased Increased Better cryptococcal clearance [22, 61] Effective T cell responses-predominantly Th1 [19] • Dysregulated compartmentspecific homeostatic immune response • Pro-inflammatory monocyte trafficking into CSF
• Lymphopenia-induced proliferation of CD4 cells [97, 98] • ART-induced re-distribution and trafficking of CD4 T cells into CSF [28]
• Naïve to effector T cell phenotype [103] Effective innate immune responses [82] Excessive CNS inflammation with tissue destruction presenting as paradoxical CM-IRIS In the setting of high fungal burden, lack of effective Th1 response and/or a Th2 predominant response leads to poor cryptococcal clearance with residual cryptococcal antigen. Monocyte trafficking into the CSF occurs with increased expression of the chemokines CCL2 and CCL3. In the absence of CD4 þ T cells prior to ART initiation, the innate immune response consists mainly of primed macrophages/monocytes that take up antigen but do not have IFN-g signaling from Th1 CD4 þ T cells to become fully activated, thus antigen-presenting cells accumulate and express suboptimal levels of innate signaling cytokines (e.g., IL-6). The confluence of factors including IL-6 from the myeloid cells and constant high-affinity major histocompatibility complex-peptide interactions resulting from partially cleared residual cryptococcal antigen in the setting of ART initiation could lead to lymphopenia-induced proliferation, expansion of CD4 þ T-cell memory cells, and effective Th1 responses against residual cryptococcal antigen. Occurring at the same time, IFN-g signaling from the expanding CD4 þ T-cell population leads to the en masse activation of primed monocytes/macrophages leading to exaggerated innate cytokine responses. These combined responses lead to excessive inflammation, tissue destruction, and within the closed CNS space, cryptococcal-IRIS involving the CNS can have morbid consequences. ART, antiretroviral therapy; CM-IRIS, cryptococcal meningitis immune reconstitution inflammatory syndrome; CNS, central nervous system; CSF, cerebrospinal fluid; IRIS, immune reconstitution inflammatory syndrome. more effective approach is to identify subclinical cryptococcal infection prior to ART and intervene preemptively with fluconazole, preventing cryptococcal meningitis and CM-IRIS, as recommended by the WHO [110] . Immunologic interventions to prevent and manage paradoxical CM-IRIS could inhibit monocyte migration into the CNS using CCR5 inhibitors, IL-6 blockade with siltuximab, inhibit TNF-a inhibitor with adalimumab, and steroids.
CONCLUSION
Cryptococcal IRIS remains a conundrum, for effective prevention, diagnosis, and management. A confluence of factors contribute to this syndrome, including initial HIV-associated CD4 þ T-cell depletion with attenuated localized inflammatory responses, followed by chemokine-driven trafficking of monocytes into the CSF, the recovery and restoration of T-cell signaling after initiating ART in the setting of dysregulated innate, adaptive, and regulatory immune responses. Our current understanding of CM-IRIS provides further insight into how these cellular interactions could be exploited to predict, prevent, and manage CM-IRIS.
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